Dr. Seema Jaitly has been asked to present at the DIA India – International PV Conference in Mumbai, India which is running 13-14 May 2016. The theme is Innovations in
Seema Jaitly defines what constitutes a medication error and explains the process for accurate recording and reporting so that risks can be assessed and reduced. Download the
24 Feb, 2016
This webinar covers the legislation around device vigilance and helps you understand what needs to be reported and how this differs from reporting for medicinal products.
16 Feb, 2016
The latest MHRA Symposium was held on 6th November 2015 in London. Find out about all the latest updates the MHRA had and an overview of some of the presentations. This
With the updated EU legislation there are more definitive requirements for post authorisation safety studies. Understand the definitions and what your obligations are. This
Seema Jaitly, Managing Director of Essjay Solutions, has been asked to speak at the UK Pharmacovigilance Day in London on Monday 19th October. As pharmacovigilance rapidly
As the EU has started to monitor marketing literature, now is a good time to revisit your literature and ensure it is compliant for the regulators; this includes reviewing for
09 Sep, 2015
It is important to stay abreast of the latest requirements in pharmacovigilance in order to meet the needs of the regulators. Seema Jaitly writes for Pharma Phorum and cuts
The new legislation has been in place for almost 3 years now and there has been a lot of experience and discussion regarding some of the practicalities of implementation. If
10 Jun, 2015
Join Dr. Seema Jaitly on her latest webinar which will look into signal detection in more detail. Great for those who are new to pharmacovigilance or embarking on signal
